JP2014500265A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500265A5
JP2014500265A5 JP2013542244A JP2013542244A JP2014500265A5 JP 2014500265 A5 JP2014500265 A5 JP 2014500265A5 JP 2013542244 A JP2013542244 A JP 2013542244A JP 2013542244 A JP2013542244 A JP 2013542244A JP 2014500265 A5 JP2014500265 A5 JP 2014500265A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
hydroxy
same
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542244A
Other languages
English (en)
Japanese (ja)
Other versions
JP6093307B2 (ja
JP2014500265A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/063295 external-priority patent/WO2012075494A1/en
Publication of JP2014500265A publication Critical patent/JP2014500265A/ja
Publication of JP2014500265A5 publication Critical patent/JP2014500265A5/ja
Application granted granted Critical
Publication of JP6093307B2 publication Critical patent/JP6093307B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542244A 2010-12-03 2011-12-05 ウイルス感染の治療および予防のための新規シクロスポリン誘導体 Expired - Fee Related JP6093307B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41932610P 2010-12-03 2010-12-03
US61/419,326 2010-12-03
PCT/US2011/063295 WO2012075494A1 (en) 2010-12-03 2011-12-05 Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Publications (3)

Publication Number Publication Date
JP2014500265A JP2014500265A (ja) 2014-01-09
JP2014500265A5 true JP2014500265A5 (enExample) 2015-02-05
JP6093307B2 JP6093307B2 (ja) 2017-03-08

Family

ID=46172312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542244A Expired - Fee Related JP6093307B2 (ja) 2010-12-03 2011-12-05 ウイルス感染の治療および予防のための新規シクロスポリン誘導体

Country Status (13)

Country Link
EP (1) EP2646043B1 (enExample)
JP (1) JP6093307B2 (enExample)
CN (1) CN103249424B (enExample)
AU (1) AU2011336266B2 (enExample)
BR (1) BR112013015771A2 (enExample)
CA (1) CA2819608C (enExample)
DK (1) DK2646043T3 (enExample)
ES (1) ES2625502T3 (enExample)
MX (1) MX350746B (enExample)
PT (1) PT2646043T (enExample)
RU (1) RU2601742C2 (enExample)
WO (1) WO2012075494A1 (enExample)
ZA (1) ZA201303610B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103153329A (zh) 2010-07-16 2013-06-12 美国科技环球有限公司 新颖的环孢霉素a衍生物在病毒感染的治疗和预防中的应用
CN103153330B (zh) 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
CA2814192A1 (en) 2010-10-12 2012-04-19 Allergan, Inc. Cyclosporin analogs
JP5805773B2 (ja) 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンアナログ
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
US9266927B2 (en) 2012-06-01 2016-02-23 Allergan, Inc. Cyclosporin A analogs
WO2014049540A2 (en) * 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
CN105960246A (zh) * 2013-03-15 2016-09-21 美国科技环球有限公司 新型环孢菌素衍生物及其用途
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
CN109476705B (zh) * 2016-05-17 2024-02-27 美国科技环球有限公司 新型环孢菌素衍生物及其用途
EP3914655B1 (en) 2019-01-24 2025-04-23 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3686252A1 (en) 2019-01-24 2020-07-29 Agfa-Gevaert Nv Radiation curable inkjet ink for manufacturing printed circuit boards
CA3128410A1 (en) * 2019-10-11 2021-04-15 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Ws-635 uses thereof in medicine
WO2021209003A1 (en) 2020-04-15 2021-10-21 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
CN112154151B (zh) * 2020-06-04 2025-04-29 中美华世通生物医药科技(武汉)股份有限公司 治疗或预防冠状病毒科感染

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
HUP9900405A3 (en) * 1995-07-17 2001-04-28 Scynexis Inc Durham Cyclosporin derivatives with anti-hiv effect
US7511013B2 (en) * 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7196161B2 (en) * 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
CN101068829B (zh) * 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
PL1802650T3 (pl) * 2004-10-01 2012-04-30 Scynexis Inc 3-Etero i 3-tioetero podstawione pochodne cyklosporyny do leczenia i zapobiegania zakażeniu wirusem zapalenia wątroby typu C
MX2011007195A (es) * 2009-01-07 2013-07-12 Scynexis Inc Derivado de ciclosporina para el uso en el tratamiento de infección de virus de hepatitis c (vhc) y virus de inmunodeficiencia humana (vih).
CA2751210C (en) * 2009-01-30 2015-04-21 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c infection
CN103153330B (zh) * 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用

Similar Documents

Publication Publication Date Title
JP2014500265A5 (enExample)
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
JP2016506962A5 (enExample)
JP2013537203A5 (enExample)
JP2019500387A5 (enExample)
JP2008514732A5 (enExample)
JP2017537940A5 (enExample)
JP2016506960A5 (enExample)
RU2007116119A (ru) Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
JP2010031025A5 (enExample)
JP2017528467A5 (enExample)
JP2013545785A5 (enExample)
JP2011513410A5 (enExample)
JP2014511891A5 (enExample)
JP2011529502A5 (enExample)
JP2014503525A5 (enExample)
JP2014511892A5 (enExample)
JP2017504635A5 (enExample)
JP2011516610A5 (enExample)
JP2016506961A5 (enExample)
JP2012522729A5 (enExample)
JP2008509166A5 (enExample)
JP2016505586A5 (enExample)
JP2010501584A5 (enExample)
JP2016517417A5 (enExample)